Publications by authors named "Gary Wolfe"

Claim this Profile
R
Reproductive and developmental toxicology studies of iminosugar UV-4.
Jeffry Shearer, Gary Wolfe, Mansoora Khaliq, Brian Kaufman, Aruna Sampath

Reprod Toxicol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigational New Drug Enabling Nonclinical Safety Pharmacology Assessment of the Iminosugar UV-4, a Broad-Spectrum Host-Targeted Antiviral Agent.
Jeffry Shearer, Gary Wolfe, Aruna Sampath, Kelly L Warfield, Brian Kaufman

Int J Toxicol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigational New Drug Enabling Nonclinical Safety Assessment of the Iminosugar UV-4, a Broad-Spectrum Host-Targeted Antiviral Agent.
Jeffry Shearer, Gary Wolfe, Aruna Sampath, Kelly L Warfield, Brian Kaufman

Int J Toxicol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical Development of EBI-005: An IL-1 Receptor-1 Inhibitor for the Topical Ocular Treatment of Ocular Surface Inflammatory Diseases.
Joseph Kovalchin, Bracken King, Allyson Masci, Elizabeth Hopkins, Jeremy Fry, Gary Wolfe

Eye Contact Lens· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel Iminosugar UV-12 with Activity against the Diverse Viruses Influenza and Dengue (Novel Iminosugar Antiviral for Influenza and Dengue).
Kelly L Warfield, Emily Plummer, Dominic S Alonzi, Gary W Wolfe, Aruna Sampath

Viruses· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Titrating beyond glycemic goal: "post-glycemic target phenomenon".
Allen B King, Dawn Clark, Gary S Wolfe

J Diabetes Sci Technol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weight versus pre-insulin-treatment assessment of insulin sensitivity to determine the starting basal insulin dose: a faster way to get to goal?
Allen B King, Dawn Clark, Gary S Wolfe

J Diabetes Sci Technol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contribution of the dawn phenomenon to the fasting and postbreakfast hyperglycemia in type 1 diabetes treated with once-nightly insulin glargine.
Allen B King, Dawn Clark, Gary S Wolfe

Endocr Pract· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The number of basal rates required to achieve near-normal basal glucose control in pump-treated type 2 diabetes.
Allen B King, Dawn Clark, Gary S Wolfe

Diabetes Technol Ther· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How much do I give? Dose estimation formulas for once-nightly insulin glargine and premeal insulin lispro in type 1 diabetes mellitus.
Allen B King, Dawn Clark, Gary S Wolfe

Endocr Pract· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accuracy of dosage volume for halfway doses in the Victoza Pen.
Allen B King, Gary S Wolfe

J Diabetes Sci Technol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of the di-(2-ethylhexyl) phthalate NOAEL for reproductive development in the rat: importance of the retention of extra animals to adulthood.
Chad R Blystone, Grace E Kissling, Jack B Bishop, Robert E Chapin, Gary W Wolfe

Toxicol Sci· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a diabetes specialist-guided primary care diabetes treatment program.
Allen B King, Gary S Wolfe

J Am Acad Nurse Pract· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a patient education booklet (SimpleStart) effect on postprandial glucose control in type 2 diabetes.
Allen B King, Gary S Wolfe, Dana U Armstrong

Diabetes Technol Ther· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring methods to extend the reach of diabetes specialist expertise into primary care clinics.
Allen King, Gary Wolfe, Susan Healy, Theresa Lineham, Steve Harrison

Diabetes Educ· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical observations of exenatide treatment.
Allen B King, Gary Wolfe, Susan Healy

Diabetes Care· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular profile and partial functional analysis of novel endothelial cell-derived growth factors that regulate hematopoiesis.
John P Chute, Garrett G Muramoto, Holly K Dressman, Gary Wolfe, Nelson J Chao

Stem Cells· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C--who should be treated?
Gary S Wolfe

Lippincotts Case Manag· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C-diagnosis and treatment.
Gary S Wolfe

Lippincotts Case Manag· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C: laboratory tests to be done before the diagnosis can be made.
Gary S Wolfe

Lippincotts Case Manag· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C: the latest epidemic.
Gary S Wolfe

Lippincotts Case Manag· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic damage detected in CD-1 mouse pups exposed perinatally to 3'-azido-3'-deoxythymidine or dideoxyinosine via maternal dosing, nursing, and direct gavage: II. Effects of the individual agents compared to combination treatment.
Kristine L Witt, Raymond R Tice, Gary W Wolfe, Jack B Bishop

Environ Mol Mutagen· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurobehavioral assessment of mice after developmental AZT exposure.
Edward D Levin, Susan Brunssen, Gary W Wolfe, G Jean Harry

Neurotoxicol Teratol· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic damage detected in CD-1 mouse pups exposed perinatally to 3'-azido-3'-deoxythymidine and dideoxyinosine via maternal dosing, nursing, and direct gavage.
Jack B Bishop, Kristine L Witt, Raymond R Tice, Gary W Wolfe

Environ Mol Mutagen· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis